乳腺派杰氏病45例临床分析

目的:研究分析乳腺派杰氏病的临床特点及影响其预后的因素.方法:对我院收治的45例经病理诊断的乳腺派杰氏病例资料进行回顾性分析.结果:45例中有乳头和/或乳晕区糜烂、出血等湿疹样表现者40例(其中伴乳头下方肿块11例);单纯表现为乳头下肿块5例;伴同侧腋窝淋巴结肿大13例.本组25例作根治术,20例作改良根治术.派杰氏病不伴深部肿块者的5年和10年生存率分别为95.5%和78.6%,而伴有深部肿块者的5年和10年生存率分别为53.8%和36.4%,两者的5年和10年的生存率比较均有统计学意义(其P值分别为＜0.01和＜0.05);无乳头下方浸润者的5年和10年生存率分别为100%和88.9%,而有乳头下方浸润者的5年和10年生存率分别为69.6%和43.8%,前者亦优于后者(P＜0.05);腋窝淋巴结阴性者的5年和10年生存率分别为92.0%和76.5%,而阳性者则分别为50.0%和25.0%,前者同样优于后者(P＜0.05).结论:乳腺派杰氏病多数有典型的临床表现,凡有湿疹样表现者均要考虑本病的可能性;本病预后的关键在于早期治疗.不伴深部肿块、没有深部浸润和腋淋巴结阴性者的手术治疗有很好效果,伴有肿块、有深部浸润和腋淋巴结阳性者的预后差,且均有统计学意义.     

湿疹样乳腺癌85例临床分析

目的探讨湿疹样乳腺癌的临床特点、诊治方法及预后因素,提高对湿疹样乳腺癌的认识。方法回顾性分析作者在韩国首尔峨山医院进修进时收集的85例湿疹样乳腺癌患者的临床资料。结果共入组85例患者,女性83例,男性2例。乳腺有湿疹样表现79例（92．9％）,伴乳腺肿块52例（61．2％）,同侧腋窝淋巴结转移27例（占本组85例的31．8％及伴乳腺肿块病例的51．9％）,均为伴有乳腺肿块的病例。52例行乳癌改良根治术,30例行乳腺单纯切除术,3例行局部切除术。单纯乳头及乳晕湿疹样乳腺癌11例（12．9％）,均为无乳腺肿块的病例,其余74例（87．1％）均合并其他类型的乳腺癌。本组5年生存率为82．1％,其中无乳腺肿块者5年生存率为93．9％,合并肿块者5年生存率为75．0％（P〈0．05）,无同侧腋窝淋巴结转移者5年率为96．6％,有转移者5年生存率为51．9％（P〈0．01）。结论湿疹样乳腺癌有特殊的临床表现,但易误诊,病灶细胞学和病理学检查可以确诊,伴乳腺肿块者应选择乳癌改良根治术,无乳腺肿块者可选择乳腺单纯切除术,预后与乳腺肿块及同侧腋窝淋巴结转移密切相关。     

乳腺Paget病35例临床分析

目的 分析乳腺Paget病的临床特点及诊断、治疗方法,使该病的诊治更趋合理.方法 回顾性分析华中科技大学附属协和医院1970年1月至2000年1月的35例乳腺Paget病的临床资料.结果 35例中有乳头、乳晕区糜烂等湿疹样表现者30例,伴乳腺肿块22例,合并其他类型乳腺癌者32例;伴同侧腋窝淋巴结转移11例.18例行乳癌根治术,13例行改良根治术,4例行乳房单纯切除术.未及肿块者5年生存率90.9%（10/11）,合并肿块者5年生存率44.4%（8/18）.结论 乳腺Paget病多有典型的临床表现,但易误诊,对乳头乳晕区有湿疹样表现者均要考虑本病的可能,常规的钼靶检查有助于发现隐匿病灶;单纯的Paget病愈后良好,可行乳房单纯切除;合并其他类型的乳腺癌者预后较差,应常规行乳房单纯切除＋同侧腋窝淋巴结清扫术,并行相应的辅助治疗.     

乳腺导管内癌20例临床分析

我院自１９７９年１月至１９９３年１２月经手术治疗乳膜癌３５７例，其中导管内癌２０例，占５．６％。首发症状为肿块者占６０％（１２／２０），乳头溢液者占２５％，乳头湿疹样改变者占１０％，肿埠伴溢液者占５％。腋窝淋巴结转移者占１０％。５年生存率９１．７％。分析认为，某些管内癌症状不典型，易漏诊、误诊，应引起重视。对术式的选择以改良根治术为首选。     

儿童乳腺导管内乳头状瘤1例

儿童乳腺导管内乳头状瘤１例崔宗树，石胜军辽宁省铁岭市中心医院（１１２００１）患者，女，１２岁。右乳房肿块１年，近半年增大，伴有间歇性浆液样乳头溢液。体检：双侧乳房对称，皮肤无桔皮样变，乳头无内陷。于右乳晕外上象限可触及约１．５×１．０ｃｍ肿块，质中等...     

乳腺Paget''s病诊治体会

目的：分析乳腺Paget‘s病的临床、病理、预后，使该病的诊治进一步合理化。方法：结合术后随访，回顾分析我院1956～1999年病理证实的Paget‘s病56例。结果：56例患者平均年龄61.5(29～76)岁；在明确诊断前，病程6月以上者20例，占35．7％；临床可触及乳房肿块者40例(71．4％)，未触及肿块者16例(28．6％)，临床可触及乳房肿块者有较高的浸润性癌发生率，且和淋巴结、病理分级等预后因素密切相关；56例患者根治术30例，改良根治术16例，单纯切除术10例，应用辅助化疗者29例，应用辅助内分泌治疗者21例，术后放疗7例。平均随访46．5(12～120)月，临床可触及乳房肿块者及未触及肿块者总生存率分别为67．5％、81.3％，log-rank检验其差别有统计学意义(P=0．03)。结论：乳腺Paget’s病较易引起患者忽视或临床误诊，应重视该病的临床表现作到早期诊断；乳腺Paget’s病有较高的浸润性癌发生率，特别对于临床可触及乳房肿块者应采取以全乳切除术为主的综合治疗，慎行保乳手术。     

男性乳腺癌(附22例临床分析)

 本文报告的22例男性乳腺癌占同期乳腺癌的1.1％,其特点为年龄高、病程长、以乳晕下或乳晕旁无痛性硬实肿块为首发症状。全部得到随访,5、10年生存率分别为68.4％和47.1％。以根治术为主的综合治疗效果最好,5、10年生存率分别为83.3％和72.7％。本文还结合文献进行了简要的讨论。     

乳头湿疹样癌诊治15例

乳头湿疹样癌（Popt氏病）是乳腺癌中相对比较少见的一种特殊类型。本院自1986年一1998年间共收治15例，现介绍如下。方法一般资料：本组15例患者均为女性，年龄35岁一67岁，中位年龄46岁。病程2个月一5年，平均明个月。右侧乳房病变11例，左侧4例。16床表现：以乳头乳是部位皮肤出现湿疹样改变为主者11例，其中1例乳头乳是糜烂破坏缺损。以乳头溢液为主要症状2例，以乳头乳晕处肿块为主者2例。主要伴有症状为：乳头乳是处皮肤搔痒6例，刺痛3例，乳头内陷3例。术前辅助检查：局部糜烂面刮徐片8例，5例找到Pagat氏细胞，其余阴性。乳头溢液…     

乳腺癌300例临床诊治分析

乳腺癌是女性常见恶性肿瘤。作者在1978年至1995年共收治乳腺癌300例，采取联会诊断方法。对不同病期、不同年龄乳腺癌选择不同术式，尤对Ⅱ、Ⅲ期乳腺癌仍以Halsted根治术与改良根治术为主要术式，以提高乳腺癌早期诊断丰与远期生存率。现报告如下：1资料本组300例乳腺癌中男性2例，女性298例、年龄21～87岁．中位年龄57．2岁，好发年龄40～60岁，全部病例以乳房肿块，乳腺异感，增厚，乳头溢血就诊，其中2例首发症状为右腋窝肿块。发现肿块至就诊时间最早5天，最长6年、肿块以乳房外上象限居多（占77％）。确诊手段300例乳腺癌中有7例因…     

乳腺髓样癌108例临床分析

本文收治女性乳腺髓样癌１０８例，占同期１２年间收治乳腺癌的８．５％。年龄２８～８０岁，中位年龄５３岁。Ⅰ期２０例，Ⅱ期６０例，Ⅲ期２５例，Ⅳ期３例。８８例行了传统根治术，１５例行了改良根治术，５例行了乳腺单纯切除术。腋淋巴结转移阳性为４３．５％。本组５．１０年生存率分别为８４％，７３％。其中典型髓样癌、不典型髓样癌５年、１０年生存率分别为８９．４％、７６．５％；８１％、６０％（Ｐ＞０．２５）。作者认为髓样癌是乳腺癌中较常见的一种病理类型，发病年龄较大，临床上多表现为乳腺内无痛性肿块，边界多较清楚，似有包膜，故与乳腺良性肿瘤较难鉴别，且易误诊。作者提出，对３５岁以上的女性乳腺内肿块，均应常规进行钼靶Ｘ线检查，细针穿刺细胞学涂片以明确诊断，必要时进行术中冰冻，以免延误诊断和治疗。     

Pathogenesis and treatment of Paget's disease of the breast

Fifty cases of Paget's disease of the breast treated surgically at The Johns Hopkins Hospital during the past 30 years were studied. Nineteen patients had Paget's disease confined to the nipple and 31 had an associated palpable tumor. An underlying intraductal or infiltrating duct carcinoma of the breast was present in each case. In six cases, the underlying tumor was 2 cm or more from the nipple with no apparent anatomic connection to the Paget lesion, and one case was encountered in whom intradermal Paget's disease develop in the area of a congenitally absent nipple. These findings support the theory of an intradermal origin for the Paget cell. Survival rates of patients with Paget's disease and a palpable breast mass were similar to those of patients with infiltrating duct carcinoma, the presence of axillary node metastases being the most important prognostic factor. Actuarial five- and ten-year survival rates were 22% and 9.9% for patients with positive nodes. The modified radical mastectomy is recommended as primary therapy for this group of patients. In contrast, none of the patients with Paget's disease of the nipple and no evidence of a palpable breast mass developed recurrent carcinoma. A total mastectomy without an axillary node dissection is the treatment of choice in this type of patient.     

Conservative management of Paget disease of the breast with radiotherapy: 10- and 15-year results

BACKGROUND: At 5-year follow-up, patients with Paget disease of the breast who were treated with breast-conserving surgery (BCS) and radiotherapy (RT) had excellent results. The current report provides 10- and 15-year rates of tumor control in the breast, as well as disease-free and overall survival rates following BCS and RT in a cohort of patients with Paget disease presenting without a palpable mass or mammographic density. METHODS: Through a collaborative review of patients treated with BCS and RT from seven institutions, 38 cases of Paget disease of the breast presenting without a palpable mass or mammographic density were identified. All patients had pathologic confirmation of typical Paget cells at time of diagnosis. Thirty-six of 38 patients had a minimum follow-up greater than 12 months and constitute the study cohort. Ninety-four percent of patients underwent complete or partial excision of the nipple-areola complex and all patients received a median external beam irradiation dose of 50 Gy (range, 45-54 Gy) to the whole breast. Ninety-seven percent of patients also received a boost to the remaining nipple or tumor bed, a median total dose of 61.5 Gy (range, 50.4-70 Gy). RESULTS: With median follow-up of 113 months (range, 18-257 months), 4 of 36 patients (11%) developed a first recurrence of disease in the treated breast only. Two of the four recurrences in the breast were ductal carcinoma in situ (DCIS) only and two were invasive with DCIS. Two additional patients had a recurrence in the breast as a component of first failure. Actuarial local control rates for the breast as the only site of first recurrence were 91% at 5 years (95% confidence interval [CI], 80-100%) and 87% (95% CI, 75-99%) at both 10 and 15 years. Actuarial local control rates for breast recurrence, as a component of first failure, were 91% (95% CI, 80-100%), 83% (95% CI, 69-97%), and 76% (95% CI, 58-94%) at 5, 10, and 15 years, respectively. No clinical factors were identified as significant predictors for breast recurrence. Five-, 10- and 15-year actuarial rates for survival without disease of 97% (95% CI, 90-100%) and 5-, 10-, and 15-year actuarial rates of overall survival of 93% (95% CI, 84-100%) at 5 years and 90% (95% CI, 78-100%) at 10 and 15 years were reported. CONCLUSIONS: These data confirm excellent rates of local control, disease-free survival, and overall survival at 10 and 15 years following BCS and RT for Paget disease of the breast. This study continues to support the recommendation of local excision and definitive breast irradiation as an alternative to mastectomy in the treatment of patients with Paget disease presenting without a palpable mass or mammographic density.     

乳头Paget‘s病：附55例报告

Fifty-five female patients with Paget's disease of the nipple treated in our Hospital from 1958 to 1987 are reported. It comprised 1.1% of all the breast carcinomas. The lesions was on the left side in 27 and on the right side in 28. The average age was 48 years. The primary lesion was in breast ducts and then invaded the nipple, areola superficially and deeper breast tissue. Dermal manifestation of Paget's disease is easily confused with chronic dermopathy. In this series, four patients (7.2%) did not have the typical symptoms so pathologic or cytologic examination was relied upon for correct diagnosis. Thirty-one patients were treated by radical mastectomy giving a 3-year disease-free rate of 70.9%. It seems that radical mastectomy is more superior to the other surgical procedures. The 3-year recurrent rate was 38% for patients with Paget's disease of the nipple coexisting with breast carcinoma, but no recurrence was found in patients with simple Paget's disease of the nipple. The 3-year survival rate was 46.4% in patients with axillary lymph node metastasis, 85.2% in patients without, 54.3% in patients with palpable masses in the breast and 85.0% in patients without. Paget's disease of the nipple coexisting with breast carcinoma, axillary lymph node metastasis, palpable breast masses has poor prognosis.     

乳头Paget病临床病理特征分析

目的 :探讨乳头Paget病临床特点、组织发生伴发病理亚型、性激素受体表达状况等临床病理特征。方法 :回顾分析了 2 1例乳头Paget病患者临床病理资料 ,光镜下重阅分析其病理学特征 ,并采用免疫组化SP法检测ER、PR水平。结果 :2 1例乳头Paget病中 17例临床触及肿块 ,4例未触及肿块 ,全部伴乳腺导管癌 ,前者伴发浸润性导管癌 14例、早期浸润性导管癌 3例 ,后者全部为导管内癌。腋窝淋巴结转移率47 6% ( 10 /2 1)。组织学亚型与淋巴结状态关系密切 ,P <0 0 5。ER阳性率2 3 8% ( 5 /2 1) ,PR阳性率 2 8 6%( 6/2 1) ,ER、PR同时阳性 2 3 8% ( 5 /2 1)。性激素受体水平与淋巴结状态关系密切 ,P <0 0 5 ,而与伴发组织学类型无关 ,P >0 0 5。结论 :本组乳头Paget病均伴发乳腺导管癌 ,伴乳腺肿块者均为浸润性导管癌 ,淋巴结转移率高 ,ER、PR低水平表达。     

Paget’s disease of the nipple in a population based cohort

Background Paget's disease of the nipple is a rare form of breast cancer characterised by the presence of intraepidermal tumour cells. It is often associated with ductal carcinoma in situ (DCIS) and/or invasive cancer in the breast parenchyma. We have studied the presentation and symptoms of Paget's disease, local control and breast cancer corrected survival following breast conserving surgery or mastectomy. Patients and methods The study is based on 223 women with histological verified Paget's disease of the nipple diagnosed between 1976 and 2001 at 13 Swedish hospitals. All women s charts were reviewed. All recurrences and deaths were registered. A comparison was made for differences in breast cancer-corrected survival (BCS) and disease-free survival (DFS) in univariate analyses. Results The median follow-up was 12 (4-28) years. In a vast majority (98%), the main presenting symptom was eczema or ulceration of the nipple. The diagnosis of an underlying breast malignancy was established in 79% of the women before surgery. A cone excision of the nipple-areola complex was performed in 43 women and 169 women had a mastectomy. Eleven elderly women were not operated. One hundred and seventeen women had a non-invasive Paget of which 40 had an underlying DCIS. Invasive cancer was seen in 68 women. In 38 cases the histopathological report did not state if the tumour was invasive or not. Thirty-three women died from breast cancer. In operated women BCS and DFS at 10 years were 87% and 82%, respectively. The 10-year BCS for non-operated patients (n = 11) was 34%. At 10 years, the cumulative local recurrence rate was 9%, 8% among women undergoing mastectomy and 16% among those treated with breast conserving surgery. In univariate analysis the type of surgery, cone excision or mastectomy, had no statistically significant impact on BCS or DFS. Risk factors for breast cancer death and recurrence were having an underlying invasive cancer compared with an in situ carcinoma and having a palpable tumour in the breast. Conclusion The main presenting symptoms were eczema or ulceration of the nipple. Patients with non invasive Pagets disease of the nipple had an excellent cancer outcome. Selected patients with Paget's disease of the nipple were treated with breast conserving surgery with survival rates similar to those achieved with mastectomy.     

Paget＇s Disease of the Breast： Clinical Analvsis of 45 Patients

Objective Paget’s disease is an uncommon breast malignancy and often misdiagnosed. If the patient is treated at an early stage, the prognosis is satisfactory. Our study analyzed the clinical characteristics of the disease and the factors influencing the prognosis. Methods Fourty-five patients with Paget’s disease who were admitted to our hospital were analyzed retrospectively. Results The most common symptoms of the disease were erosion and a bleeding-like eczematoid change at the nipple/areola. Of the 40 patients with an eczematoid change, 11 patients had verified Paget’s disease with a palpable mass on physical examination, and 29 patients had verified Paget’s disease with a nonpalpable mass. Only 5 patients manifested a mass with no eczematiod change. Thirteen patients had ipsilateral axillary lymphadenopathy. In this study, 25 cases were treated by radical mastectomy and 20 cases were treated by modified radical mastectomy. Five and 10-year survival rates for the patients with nonpalpable masses and for those with palpable masses were 95.5%, 78.6%, and 53.8%, 36.4% respectively. The former were significantly higher than the latter (P <0.01 and <0.05 respectively). Five and 10-year survival rates for the patients without underlying carcinoma (DCIS/IDC) and for the patients with underlying carcinoma were 100%, 88.9% and 69.6%, 43.8% respectively. The former were significantly higher than the latter ( P<0.05) Five and 10-year survival rates for the patients with negative lymph nodes and for the patients with positive lymph nodes were 92.0%, 76.5% and 50.0%, 25.0% respectively. The former were also significantly higher than the latter (P<0.05). Conclusion Treatment at an early stage is very important and influences the prognosis directly for Paget’s disease of the breast. The survival rates of patients with nonpalpable masses without underlying carcinoma and without lymphadenopathy, were significantly higher than patients with palpable masses with underlying carcinoma and with lymphadenopathy respectively. There was significant statistical difference between each of the 2 groups.     

Patients with Paget disease of nipple and with palpable mass in breast have unfavorable prognosis

Recent data indicate that in breast cancer patients the presence of Paget disease of the nipple may be related to poor prognosis. Therefore, we decided to assess long-term results of the treatment of such patients, and to assess the relationship between the physical and pathological findings and prognosis. The files of 60 patients with Paget disease of the nipple who were treated between 1977 and 2000 were analyzed retrospectively with respect to the results of physical and pathologic examinations, disease recurrence and survival. In 38/60 patients, the cancer was invasive. In 26/60 patients, palpable masses in the breast were diagnosed. The 5-year overall survival probability was 0.68; the probability was 0.82 for patients without palpable masses, 0.51 for those with palpable masses, 0.91 for patients without invasive cancer and 0.58 for patients with associated invasive cancer. In conclusions, patients with Paget disease of the nipple and with palpable mass in the breast had unfavorable diagnosis. The nature of all nipple changes should be explained as early as possible in order to diagnose the disease when no mass is palpable in the breast.     

Paget disease of the nipple: a multifocal manifestation of higher-risk disease

BACKGROUND: The treatment of Paget disease by mastectomy has been challenged recently in favor of breast-conserving techniques. A large series of patients treated with mastectomy has been reviewed to assess the feasibility of less radical surgery. METHODS: The cases of 70 women with a clinical diagnosis of Paget disease were reviewed. The type, grade, receptor and node status, and the mammographic and pathologic extent of the underlying breast malignancy were determined. The survival of patients with invasive disease was compared with matched controls without Paget disease. RESULTS: The underlying malignancy was invasive in 58% of cases. Despite the fact that only one third of women presented with a palpable mass, the malignancy was frequently extensive, being confined to the retroareolar region in only 25% of cases. The true extent of the disease was underestimated by mammography in 43% of cases. Of the patients with ductal in situ carcinoma, 96.5% had high-grade carcinomas and 100% had invasive carcinomas of high cytonuclear grade. Overexpression of the c-erb-B2 oncogene was detectable in 83% of cases. Patients with Paget disease had a significantly worse survival than matched controls, but this difference was eliminated if they were also matched for c-erb-B2 status. CONCLUSIONS: Paget disease is often associated with extensive underlying malignancy, which is difficult to assess accurately either clinically or mammographically. As a consequence, cone excision of the nipple would have resulted in incomplete excision in 75% of cases. The underlying disease is of high grade and is frequently c-erb-B2 positive with a resulting poor prognosis. Aggressive local and systemic treatment would seem to be merited.     

Paget disease of the breast—an easily overlooked disease?

BACKGROUND AND OBJECTIVES: Paget disease of the breast has long been recognized as a distinct clinical disease. The clinical manifestations and outcomes of Paget disease of the breast were reviewed to understand its earlier diagnostic clues and achieve an optimal treatment plan. Patients and Methods Thirty-one patients with Paget disease of the breast were included in this study. The postoperative outcomes and possible related prognostic factors were reviewed and analyzed. RESULTS: The 5-year overall survival was 69%. Nineteen patients (61%, Group A) did not have a palpable breast mass and 12 patients (39%, Group B) had a palpable breast mass. There was significant difference (P < 0.01) in the 5-year overall survival between Group A (94%) and Group B (19%). Group A patients had significantly higher incidences of underlying noninvasive breast carcinoma (73% vs. 8%, P < 0.01) and n0 lymph nodes status (84%vs. 50%, P = 0.043) than those of Group B. CONCLUSIONS: Paget disease of the breast without a palpable breast mass carries a more favorable prognosis. Patients with any nipple complaints deserve a detailed evaluation even in the absence of a palpable breast mass in order not to overlook a favorable disease.